Table 3 Trend in personal payments from pharmaceutical companies to board-certified allergists between 2016 and 2020
Variables | 2016 | 2017 | 2018 | 2019 | 2020 | Average relative yearly change between 2016 and 2019 (95% CI), % | Relative change rate between 2016–2019 and 2020 (95% CI), % |
|---|---|---|---|---|---|---|---|
All pharmaceutical companies | Â | Â | Â | Â | Â | Â | Â |
Total payments, $ | 7,821,861 | 8,274,237 | 8,953,824 | 9,981,069 | 8,354,293 | – | – |
Payments per allergist | Â | Â | Â | Â | Â | Â | Â |
Mean (standard deviation), $ | 4,819 (11,395) | 5,204 (12,305) | 5,517 (12,200) | 6,002 (13,243) | 5,892 (13,200) | 7.7 (5.0–10.6)* | -21.2 (-25.4 to -16.8)* |
Median (interquartile range), $ | 1,332 (521–3,898) | 1,435 (521–3,974) | 1,526 (521–4,521) | 1,535 (539–5,021) | 1,518 (539–4,674) | ||
Maximum, $ | 167,946 | 155,035 | 125,560 | 154,826 | 131,500 | ||
Physicians with payments (%), n | 1623 (41.2) | 1590 (40.3) | 1623 (41.2) | 1663 (42.2) | 1418 (36.0) | 0.9 (-0.1 to 2.1) | -14.8 (-17.9 to -11.5)* |
Gini index | 0.888 | 0.890 | 0.888 | 0.885 | 0.904 | – | – |
Pharmaceutical companies making payments throughout five years | Â | Â | Â | Â | Â | Â | Â |
Total payments, $ | 7,645,832 | 8,192,889 | 8,710,193 | 9,653,679 | 8,144,163 | – | – |
Payments per allergist | Â | Â | Â | Â | Â | Â | Â |
Mean (standard deviation), $ | 4,782 (11,289) | 5,208 (12,254) | 5,468 (12,085) | 6,015 (13,280) | 5,919 (13,171) | 7.2 (4.4–10.0)* | -20.4 (-24.6 to -15.9)* |
Median (interquartile range), $ | 1,317 (521–3,873) | 1448 (521–3,990) | 1,526 (521–4,495) | 1,564 (547 − 4,931) | 1,526 (539–4,666) | ||
Maximum, $ | 166,980 | 155,035 | 125,560 | 154,826 | 130,757 | ||
Physicians with payments (%), n | 1599 (40.6) | 1573 (39.9) | 1593 (40.4) | 1605 (40.7) | 1376 (34.9) | 0.2 (-0.9 to 1.3) | -14.8 (-17.4 to -10.7)* |
Gini index | 0.889 | 0.891 | 0.889 | 0.889 | 0.906 | – | – |